標(biāo)題： 1、Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial 2、Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study 3、Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers 4、Development and in vitro/in vivo evaluation of immediate release perindopril tablets 5、The advantages of combination therapy on hypertension: development of immediate release perindoprilindapamide tablet and assessment of bioequivalence studies 6、Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? - PubMed - NCBI 7、Drug Dev Ind Pharm. 2013 Jul;39(7):996-1004. doi: 10.3109/03639045.2012.689765. Epub 2012 May 25. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Shi Y1, Zou M, An Y, Ji Z, Gao P, Cheng G. 8、Drug Dev Ind Pharm. 2006 Jul;32(6):651-60. Production of an extremly low dose procaterol HCl preparation by fluidized-bed coating method: in vitro and in vivo evaluation. Yu TW1, Chen RR, Gau CS. 9、Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Park JH, Choi HK. Arch Pharm Res. 2015 Jul;38(7):1336-44. doi: 10.1007/s12272-014-0547-6. Epub 2015 Jan 8. 10、Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. Drug Dev Ind Pharm. 2017 Feb;43(2):283-292. doi: 10.1080/03639045.2016.1239627. Epub 2016 Oct 6. 要求：將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

求購“Metformin hydrochloride”《 EP9.1 》《 EP9.2 》的藥典標(biāo)準(zhǔn)一份，Metformin hydrochloride Tablets”《 USP42 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求購標(biāo)準(zhǔn)全文，Ketoconazole Shampoo 2017，F(xiàn)ormulated Preparations: Specific Monographs: Ketoconazole Shampoo BP2019   [更多]

求購“Ambroxol hydrochloride”《 EP9.2》的藥典標(biāo)準(zhǔn)一份，多謝。   [更多]

求購“Alumina and Magnesium Trisilicate Tablets”-USP42、Compound Magnesium Trisilicate Tablets-BP2020、Chewable Compound Magnesium Trisilicate Tablets-BP2020、Chewable Aluminium Hydroxide Tablets-BP2020、Chewable Aluminium Hydroxide and Magnesium Trisilicate Tablets-BP2020等最新藥典。   [更多]

文獻(xiàn)完整，準(zhǔn)確   [更多]

文獻(xiàn)均來自德國期刊，Arzneimittelforschung。要求是完整的文獻(xiàn)，必須完成第1篇。另請注意，英文標(biāo)題是翻譯過來的，原文標(biāo)題是德語。 1 [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)]. Hammer R, Bozler G, Jauch R, Koss FW, Hadamovsky H.Arzneimittelforschung. 1978;28(5a):899-903. 2 [Results of some clinical-pharmacological studies on ambroxol (NA 872)]. Renovanz VK.Arzneimittelforschung. 1975 Apr;25(4):646-52.PMID: 1174081 German. 3 Results from experimental studies in animals with the metabolite VIII of bromhexine (N-[trans-4-hydroxy-cyclohexyl]=[2-amino-3,5-dibromo-benzyl]-amine, Ambroxol (NA 842)) are described in order to contribute to the understanding of this substance's mode of action. ... 4 [Ambroxol, studies of biotransformation in man and determination in biological samples (author's transl)]. Jauch R, Bozler G, Hammer R, Koss FW, Karlsson M, Vitek E, H?ring I, Beschke K, Hadamovsky S, Maass D, Wollmann R.Arzneimittelforschung. 1978;28(5a):904-11. 5 [Pharmacological study on the bromhexine metabolite ambroxol (author's transl)]. Püschmann S, Engelhorn R.Arzneimittelforschung. 1978;28(5a):889-98.   [更多]

求利巴韋林美國藥典、英國藥典、歐洲藥典原料藥及制劑質(zhì)量標(biāo)準(zhǔn)   [更多]

求助阿比朵爾原料及制劑俄羅斯藥典標(biāo)準(zhǔn)（或其他來源的質(zhì)量標(biāo)準(zhǔn)，說明來源）   [更多]

DrugsoftheFuture（DOF）2021年1-3期 文獻(xiàn)必須完整、準(zhǔn)確   [更多]